Deutschlands großes Presseportal - Homepage
» kostenlos Pressemitteilung veröffentlichen
» Kunden Login zu "meine Redaktion"
»Suche / Lokale Suche
> Startseite > Gesundheit & Medizin

Migraine Drugs Market is Expected to Reach Approximately US$ 3.72 bn in Revenues by 2025-End

Currently, savvy companies operating in the global migraine drugs market are expending time and money into research and development of new and more effective drugs.
This is because they have sensed an opportunity in the considerable unmet needs of patients in the absence of a complete cure and also because of the growing genericization of drugs. More players are expected to foray into the market to tap into the opportunities.

Some of the prominent participants in the global migraine drugs market are AstraZeneca Plc., Allergan Plc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Eli Lilly & Co. Novartis AG, Merck & Co., Inc., Valeant Pharmaceutical International, Inc., Janssen Pharmaceutical Company (Johnson & Johnson), Endo Pharmaceuticals Inc., Zosano Pharma Corporation, Alder BioPharmaceuticals Inc., Avanir Pharmaceuticals, Inc., and Eisai Co., Ltd.

A research study by Transparency Market Research states that the global migraine drugs market was worth US$2.72 bn in 2016. The report forecasts the market to attain a value of US$3.72 bn by 2025 by registering a tepid CAGR of 3.5% from 2017 and 2025.

Request to Download and View Full TOC @ https://www.transparencymarketresearch.com/report-toc/31136
The global market for migraine drugs can be divided based on the types of treatments into abortive treatment and prophylactic treatment. The abortive treatment can be divided further into triptans, ergot alkoids, etc. The prophylactic treatment segment too can be segmented again into botulinum toxin, topiramate, etc. At present, the segment of abortive treatment, powered mainly by triptans, leads the market with a higher share.

Geography-wise, the main segments of the global migraine drugs market are North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among them, North America, at present holds a dominant share in the market because of the higher allocations on healthcare, growing instances of migraine, and availability of specialty migraine drugs. In the years ahead too, North America is predicted to hold on to its leading share. By 2025, it is expected to rake in a revenue of US$2.13 bn.

Request to View Sample Report @ https://www.transparencymarketresea....e.php?flag=S&rep_id=31136


Rising Female Population Proves Beneficial to Market

Migraine is a common disease that afflicts almost 14.7% of the world population. As per the World Health Organization, its prevalence is estimated to be 12% among general population. It is found that females are 2 to 3 times more susceptible to the chronic condition. With the rise of the female population and the increase in overall population, particularly in developing nations, the global migraine drugs market will be boosted majorly in the next couple of years.

Serving to hinder the market, on the other hand, is the easy availability of generics and over reliance on over the counter (OTC) pain killers and other drugs in emerging and under developed markets. The lead analyst of the TMR report observes, “Companies that manufacture and sell migraine drugs that exhibit a high safety and efficacy profile are expected to gain a competitive edge over their peers.”

Buy Full Migraine Drugs Market Report @ https://www.transparencymarketresea.....php?rep_id=31136<ype=S

17.10.2017 14:34

Das könnte auch Sie interessieren:

Trichomoniasis Drugs Market Poised to Garner Maximum Revenue...
Trichomoniasis is a sexually transmitted disease (STD) which is caused by the flagellated protozoan parasite passed from one person to another during sex; the parasite usually transmits from a vagina to a penis or from penis to a vagina, and some...

Gummy Vitamins Market to Reach US$ 4.17 bn by 2025
Some of the prominent players in the global gummy vitamins market are ABH Labs, LLC, Boli Naturals LLC, Vitakem Nutraceutical Inc., Ferrara Candy Company, Gimbal Brothers, Inc., Bayer AG, Melrob Group, Makers Nutrition, LLC, Santa Cruz...

Computer Keyboards Market expected to grow at a CAGR of 2.3%...
Introduction Ergonomic keyboards are designed to incorporate ergonomic considerations such as unique angled design, key sensitivity, and wrist support - allowing the wrists and hands to rest and move more naturally while operating keyboards....

Automotive Bearings Market Expected to Expand at a Steady CA...
Bearings are used to enable rotational or linear movement, and to disable the unwanted friction and handling stress. Bearings are integrated in automotive to constrain the relative motion and allow desired motion, due to which, a vehicle can...

Data Storage Market expected to grow at a CAGR of 14.4% duri...
Introduction The data storage market is classified into two broad categories: consumer data storage devices and enterprise data storage. Consumer data storage devices include hard disk drives and USB flash drives are used for storing personal...

Atomic Absorption Spectrometer Market Expected to Expand at ...
The global atomic absorption spectrometer market has witnessed prodigious growth over the last few years. With the increasing use of atomic absorption spectrometer in various applications such as clinical analysis, environmental analysis and many...

Cetyl Alcohol Market Intelligence and Forecast by Transparen...
Cetyl alcohol is a long chain of organic alcohol. They are also known by various other chemical names such as 1-Hexadecanol, cetanol, Hexadecan-1-ol, N-Hexadecyl alcohol or palmityl alcohol. Under room temperature, Cetyl alcohol is usually in the...

3D Printed Drugs Market Volume Analysis, Segments, Value Sha...
3D printing was pioneered way back in 1986 but has recently begun to enter the public consciousness. Over the past ten years, it has blurred the boundaries between science fiction and fact. It is also known as Additive Manufacturing and is used in...

IHE XDS.B Market Expected to Expand at a Steady CAGR through...
IHE XDS.b also known as Cross-Enterprise Document Sharing is one of the latest technology, which is widely used in the healthcare to share and secure the information of patient’s primary and secondary clinical documents. The IHE XDS.b enables data...

Acerola Extract Market Expected to Witness a CAGR of 8.5% th...
Future Market Insights delivers key insights on the global acerola extract market in a new publication titled “Acerola Extract Market: Global Industry Analysis and Opportunity Assessment, 2016–2026.” The global acerola extract market is projected...

Λ nach oben

Stichwort-Suche:

Pressemitteilung von:


Transparency Market Research

90 State Street, Suite 700, Albany, NY 12207

Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight...

mehr »

 

 


Hinweis: Um Ihnen ein optimales Nutzererlebnis zu bieten, verwenden wir Cookies. Durch die Nutzung dieser Webseite erklären Sie sich damit einverstanden.   Nachricht schließen   mehr info